BLADDER TRANSITIONAL CELL CARCINOMA STAGE I

BLADDER TRANSITIONAL CELL CARCINOMA STAGE I was reported 46 times

BLADDER TRANSITIONAL CELL CARCINOMA STAGE I is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glinide [EPC] 1 0.0001
1 Provitamin D2 Compound [EPC] 2 0.0001
2 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
3 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
4 Interleukin-17A Antagonist [EPC] 1 0.0000
5 Integrin Receptor Antagonist [EPC] 2 0.0000
6 Pyrimidine Synthesis Inhibitor [EPC] 1 0.0000
7 Angiotensin Converting Enzyme Inhibitor [EPC] 3 0.0000
8 Purine Antimetabolite [EPC] 2 0.0000
9 Folate Analog [EPC] 1 0.0000
10 Vitamin A [EPC] 1 0.0000
11 Parathyroid Hormone Analog [EPC] 2 0.0000
12 Nicotinic Acid [EPC] 1 0.0000
13 Antidote [EPC] 1 0.0000
14 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
15 Prostaglandin Analog [EPC] 1 0.0000
16 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
17 Estrogen [EPC] 2 0.0000
18 Aminosalicylate [EPC] 1 0.0000
19 Vitamin D [EPC] 3 0.0000
20 Thiazide Diuretic [EPC] 2 0.0000
21 Vitamin C [EPC] 4 0.0000
22 Vitamin B12 [EPC] 3 0.0000
23 Sulfonylurea [EPC] 1 0.0000
24 Fluoroquinolone Antibacterial [EPC] 1 0.0000
25 alpha-Adrenergic Blocker [EPC] 1 0.0000
26 Corticosteroid [EPC] 9 0.0000
27 Proton Pump Inhibitor [EPC] 4 0.0000
28 beta-Adrenergic Blocker [EPC] 2 0.0000
29 Aldosterone Antagonist [EPC] 1 0.0000
30 Angiotensin 2 Receptor Blocker [EPC] 2 0.0000
31 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
32 Platelet Aggregation Inhibitor [EPC] 3 0.0000
33 Interferon beta [EPC] 1 0.0000
34 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
35 Benzodiazepine [EPC] 3 0.0000
36 Alkylating Drug [EPC] 1 0.0000
37 Thalidomide Analog [EPC] 2 0.0000
38 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
39 Factor Xa Inhibitor [EPC] 1 0.0000
40 Kinase Inhibitor [EPC] 1 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 1 0.0000